Relay Therapeutics, Inc. Common Stock (RLAY) Stock Price

RLAYStock

$20.57+470.09%52W

Market Cap$4.51B

P/E—

PEG Ratio—

Div yield—

Beta1.70

RLAY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)100.09%

Price vs S&P 500 (4W)0.69%

VGM Score42.78

Book Value / Share (Quarterly)$4.07

P/TBV (Annual)2.59x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)123.25%

Cash Flow / Share (Quarterly)$-0.97

Price vs S&P 500 (YTD)117.50%

Net Profit Margin (TTM)-2047.23%

EPS (TTM)$-1.57

10-Day Avg Trading Volume2.15M

EPS Excl Extra (TTM)$-1.57

Revenue Growth (5Y)-28.58%

EPS (Annual)$-1.61

ROI (Annual)-48.76%

Net Profit Margin (5Y Avg)-7914.86%

Cash / Share (Quarterly)$4.17

Revenue Growth QoQ (YoY)-48.30%

ROA (Last FY)-44.50%

Revenue Growth TTM (YoY)23.86%

EBITD / Share (TTM)$-1.69

ROE (5Y Avg)-41.75%

Operating Margin (TTM)-2222.65%

Cash Flow / Share (Annual)$-1.36

P/B Ratio4.91x

P/B Ratio (Quarterly)4.53x

Net Income / Employee (Annual)$-1,440,000

EV / Revenue (TTM)410.69x

ROA (TTM)-38.67%

EPS Incl Extra (Annual)$-1.61

Current Ratio (Annual)22.61x

Quick Ratio (Quarterly)18.10x

3-Month Avg Trading Volume3.56M

52-Week Price Return470.09%

Revenue / Employee (TTM)$53,900

Tangible BV / Share (Quarterly)$3.26

P/S Ratio (Annual)284.72x

Asset Turnover (Annual)0.02x

52-Week High$21.27

Operating Margin (5Y Avg)-8175.41%

EPS Excl Extra (Annual)$-1.61

CapEx CAGR (5Y)-26.64%

26-Week Price Return112.23%

Quick Ratio (Annual)21.91x

13-Week Price Return49.31%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)18.27x

Enterprise Value$4.25B

Revenue / Share Growth (5Y)-37.24%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-17.42%

Revenue / Employee (Annual)$80,000

Pretax Margin (Annual)-1800.58%

Cash / Share (Annual)$3.19

3-Month Return Std Dev57.95%

Net Income / Employee (TTM)$-1,489,800

ROE (Last FY)-48.76%

EPS Basic Excl Extra (Annual)$-1.61

Receivables Turnover (TTM)19.65x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.57

Receivables Turnover (Annual)9.83x

ROI (TTM)-42.27%

P/S Ratio (TTM)422.40x

Pretax Margin (5Y Avg)-7914.86%

Revenue / Share (Annual)$0.09

Tangible BV / Share (Annual)$3.26

Price vs S&P 500 (52W)449.61%

Year-to-Date Return129.79%

5-Day Price Return-5.95%

EPS Normalized (Annual)$-1.61

ROA (5Y Avg)-37.25%

Net Profit Margin (Annual)-1800.58%

Month-to-Date Return3.24%

Cash Flow / Share (TTM)$-2.64

EBITD / Share (Annual)$-1.74

Operating Margin (Annual)-1971.59%

ROI (5Y Avg)-41.75%

EPS Basic Excl Extra (TTM)$-1.57

P/TBV (Quarterly)2.59x

P/B Ratio (Annual)2.59x

Pretax Margin (TTM)-2047.23%

Book Value / Share (Annual)$3.26

Price vs S&P 500 (13W)46.01%

Beta1.70x

Revenue / Share (TTM)$0.05

ROE (TTM)-42.27%

52-Week Low$3.31

vGradeF

gGradeD

mGradeA

vgmGradeC

RLAY Earnings Surprise History

Q2 25-0.41est. -0.47

Q3 25-0.43est. -0.42

Q4 25-0.31est. -0.40

Q1 26-0.41est. -0.36

Q2 26-0.41est. -0.39

RLAY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.32

4.37

4.33

4.30

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About Relay Therapeutics, Inc. Common Stock

Relay Therapeutics is a clinical-stage precision medicine company using its proprietary Dynamo platform—which combines computational and experimental approaches—to target difficult drug-protein interactions in precision oncology and genetic disease. The company is advancing a pipeline of candidates including RLY-8186, RLY-2608, and RLY-4008.